Spotlight Session - Cell & Gene Therapy

(CSPOT41) Effectiveness of Axicabtagene Ciloleucel versus Conventional Treatments as First-line Therapy in Patients With High-risk Large B-cell Lymphoma: a Retrospective External Comparator Study

(CSPOT42) Stem Cell Therapy in Avascular Necrosis: Systematic Review and Meta-Analysis of Randomized Controlled Trials

(CSPOT43) Risk Management of Authorised Advanced Therapy Medicinal Products in the EU

(CSPOT44) Planned and Ongoing EMA-mandated Post-approval Observational Studies of Cell & Gene Therapies (CGT): What Can We Learn from Study Characteristics?

(CSPOT45) Post-marketing Safety Assessment of CAR T-cell Therapies: Analysis of Individual Case Safety Reports in the VigiBase